Data from the World Health Organization’s Global TB Report 2025 confirms that India is on an accelerated trajectory toward tuberculosis elimination, with new cases dipping by 21% and mortality dropping by 28% between 2015 and 2024.
This progress is underpinned by the National TB Elimination Programme (NTEP), which aims to eliminate the disease by 2025—five years ahead of the global SDG target. A massive 100-Day TB Mukt Bharat Abhiyaan, launched in December 2024, screened over 20 crore vulnerable citizens and diagnosed 28 lakh patients, including 9 lakh asymptomatic cases who otherwise might have been missed.
To modernize care, India has institutionalized the BPaLM regimen, reducing drug-resistant TB treatment to just six months, and deployed the world's largest diagnostic network consisting of 9,800 rapid molecular testing facilities.
Community involvement is driven by the Ni-kshay Mitra initiative, where over 6.7 lakh volunteers provide nutritional and vocational support to patients. This is complemented by the Nikshay Poshan Yojana, which has disbursed over ₹4,454 crore directly to 1.38 crore beneficiaries to ensure the high-protein diet required for recovery.
Strategic Pillars and Technological Integration
Pillar 1: Detect & Build: India utilizes DeepCXR (Radiology AI) for automated X-ray analysis and Cough Against TB (Acoustic AI) to identify infection signatures via a 3-second smartphone recording.
Pillar 2: Treat & Prevent: The BPaLM regimen (Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin) marks a paradigm shift in managing multi-drug resistant TB with safer, shorter protocols.
Pillar 3: precision Triage: AI-enabled predictive analytics now flag high-risk patients for potential treatment failure, leading to a 27% decline in adverse outcomes nationwide.
Pillar 4: Accessible Care: Diagnosis and treatment are decentralized through 1,84,726 Ayushman Arogya Mandirs, providing universal and affordable health services at the community level.
What is a "Ni-kshay Mitra"? A Ni-kshay Mitra (meaning "TB Friend") is a volunteer—ranging from individuals and NGOs to corporations and elected representatives—who provides additional support to TB patients during their treatment. It acts as a catalyst for treatment adherence by addressing social determinants of health through three specific types of support: nutritional (providing monthly food baskets), psychosocial (regular check-ins), and vocational (rebuilding livelihoods post-recovery). This mechanism is manifests as a transition from a purely clinical patient-doctor relationship to a broad-based "Jan Andolan" or people’s movement. Engaging Ni-kshay Mitras is a primary lever for the NTEP to reduce out-of-pocket expenditures for patients, which is critical given that TB treatment lasts a minimum of six months.
What is the "BPaLM Regimen"? The BPaLM regimen is a novel, highly effective treatment protocol for drug-resistant tuberculosis consisting of four specific drugs: Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin. It acts as a catalyst for patient compliance by reducing the traditional 18–24 month treatment period to a standardized 6-month duration. This mechanism is manifests as a transition from long, often toxic treatment cycles to a shorter, safer outpatient model. Implementing BPaLM is a primary lever for the NTEP to bypass the specialist shortages and high dropout rates associated with older drug-resistant TB therapies, ensuring more patients reach "cured" status with fewer side effects.
Policy Relevance: Health Sovereignty through Local Action
Institutionalizes a Framework for Local Accountability: Awarding TB-free certification to 46,118 Gram Panchayats benchmarks a trajectory where public health success is measured and celebrated at the village level.
Mechanically Bridges the Diagnostic Gap in Remote Areas: The use of hand-held AI-enabled X-ray units in regions like the Gurez Valley (2,400m high) signals a paradigm shift in reaching "last-mile" populations cut off by geography.
De-risks the Treatment Cycle via Social Support: Enrolling 2 lakh "My Bharat" youth volunteers as Ni-kshay Mitras serves as a cornerstone for building a sustainable, intergenerational support system for TB patients.
Signals a Paradigm Shift in AI-Integrated Healthcare: The deployment of Acoustic AI (CATB) to screen coughs via smartphones act as a primary lever for non-invasive, low-cost screening that can be scaled without expensive laboratory equipment.
Solidifies India’s Standing in Global Health Governance: Achieving a 90% treatment success ratebenchmarks India’s capability to outperform global averages (88%) while managing the world's highest TB burden.
Relevant Question for Policy Stakeholders: How does the introduction of the BPaLM regimen impact the supply chain requirements for the Ayushman Arogya Mandirs, particularly regarding cold-chain storage for new-age antibiotics?
Follow the Full News Here: India Speeding Towards TB Elimination
